Clinical trial
Side Effects of Antipsychotic Medications
NCT00363181 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00363181 |
|---|---|
| Title | Side Effects of Antipsychotic Medications |
| Official title | Does Olanzapine Inhibit the Secretory Response to Insulin Resistance? |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Insulin Resistance, Metabolic Syndrome X, Schizophrenia and Disorders With Psychotic Features, Mood Disorders, Psychotic Disorders |
| Enrollment | 76 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Aug 15, 2006 |
| Last update posted | Mar 22, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: